HK1039778A1 - 製造聯苯異噁唑基磺胺的方法 - Google Patents
製造聯苯異噁唑基磺胺的方法Info
- Publication number
- HK1039778A1 HK1039778A1 HK02101358.2A HK02101358A HK1039778A1 HK 1039778 A1 HK1039778 A1 HK 1039778A1 HK 02101358 A HK02101358 A HK 02101358A HK 1039778 A1 HK1039778 A1 HK 1039778A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparation
- methods
- isoxazole sulfonamides
- biphenyl isoxazole
- biphenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
- C07C303/22—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof from sulfonic acids, by reactions not involving the formation of sulfo or halosulfonyl groups; from sulfonic halides by reactions not involving the formation of halosulfonyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
- C07D261/16—Benzene-sulfonamido isoxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
- C07D263/50—Benzene-sulfonamido oxazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12514899P | 1999-03-19 | 1999-03-19 | |
PCT/US2000/005521 WO2000056685A1 (en) | 1999-03-19 | 2000-03-02 | Methods for the preparation of biphenyl isoxazole sulfonamides |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1039778A1 true HK1039778A1 (zh) | 2002-05-10 |
Family
ID=22418402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02101358.2A HK1039778A1 (zh) | 1999-03-19 | 2002-02-22 | 製造聯苯異噁唑基磺胺的方法 |
Country Status (11)
Country | Link |
---|---|
US (1) | US6313308B1 (zh) |
EP (1) | EP1165472A4 (zh) |
JP (1) | JP2002540088A (zh) |
KR (1) | KR20020004974A (zh) |
AU (1) | AU3718900A (zh) |
CA (1) | CA2367916A1 (zh) |
HK (1) | HK1039778A1 (zh) |
HU (1) | HUP0201320A2 (zh) |
IL (1) | IL144708A0 (zh) |
MX (1) | MXPA01009362A (zh) |
WO (1) | WO2000056685A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0201320A2 (en) * | 1999-03-19 | 2002-08-28 | Bristol Myers Squibb Co | Methods for the preparation of biphenyl isoxazole sulfonamides and intermediates thereof |
US6639082B2 (en) | 2000-10-17 | 2003-10-28 | Bristol-Myers Squibb Company | Methods for the preparation of biphenyl isoxazole sulfonamides |
WO2004021997A2 (en) * | 2002-09-06 | 2004-03-18 | Microbia, Inc. | Inhibitors of fungal invasion |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB804036A (en) | 1956-03-02 | 1958-11-05 | Hoffmann La Roche | A process for the manufacture of a sulphanilamide of the isoxazole series |
CH364506A (de) | 1956-09-04 | 1962-09-30 | Shionogi & Co | Verfahren zur Herstellung des therapeutisch wirksamen 3-Sulfanilamido-5-methyl-isoxazols |
DE1059459B (de) | 1956-09-04 | 1959-06-18 | Shionogi & Co | Verfahren zur Herstellung des therapeutisch wertvollen 3-Sulfanilamido-5-methylisoxazols |
US2888455A (en) | 1956-09-04 | 1959-05-26 | Shionogi & Co | New sulfonamide and process for producing the same |
GB897440A (en) | 1960-02-08 | 1962-05-30 | Shionogi & Co | Improvements in or relating to sulfonamides |
GB1473433A (zh) | 1975-10-09 | 1977-05-11 | Banyu Pharmaceutical Co Ltd Hi | |
US4415496A (en) | 1981-03-23 | 1983-11-15 | Merck & Co., Inc. | Bicyclic lactams |
EP0076072B1 (en) | 1981-09-24 | 1987-05-13 | BEECHAM - WUELFING GmbH & Co. KG | Sulphonamides |
US4661479A (en) | 1982-02-19 | 1987-04-28 | Merck And Co., Inc. | Bicyclic lactams as antihypertensives |
EP0194548A3 (de) | 1985-03-12 | 1988-08-17 | Dr. Karl Thomae GmbH | Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
US5571821A (en) | 1993-05-20 | 1996-11-05 | Texas Biotechnology Corporation | Sulfonamides and derivatives thereof that modulate the activity of endothelin |
US5514691A (en) | 1993-05-20 | 1996-05-07 | Immunopharmaceutics, Inc. | N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin |
US5464853A (en) | 1993-05-20 | 1995-11-07 | Immunopharmaceutics, Inc. | N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
US5591761A (en) | 1993-05-20 | 1997-01-07 | Texas Biotechnology Corporation | Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
CA2005741C (en) | 1988-12-26 | 1998-06-02 | Hiroyoshi Hidaka | Quinoline sulfonoamino compounds having vessel smooth muscle relaxation activity |
US5082838A (en) | 1989-06-21 | 1992-01-21 | Takeda Chemical Industries, Ltd. | Sulfur-containing fused pyrimidine derivatives, their production and use |
DK0443983T3 (da) | 1990-02-19 | 1996-03-18 | Ciba Geigy Ag | Acrylforbindelser |
WO1991015479A1 (en) | 1990-03-30 | 1991-10-17 | Merck & Co., Inc. | Substituted pyrazoles, isoxazoles and isothiazoles |
US5236928A (en) | 1991-03-19 | 1993-08-17 | Merck & Co., Inc. | Imidazole derivatives bearing acidic functional groups at the 5-position, their compositions and methods of use as angiotensin II antagonists |
TW270116B (zh) | 1991-04-25 | 1996-02-11 | Hoffmann La Roche | |
RU2086544C1 (ru) | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
PL176250B1 (pl) | 1991-11-05 | 1999-05-31 | Smithkline Beecham Corp | Sposób wytwarzania pochodnych indanu |
SE9103397D0 (sv) | 1991-11-18 | 1991-11-18 | Kabi Pharmacia Ab | Nya substituerade salicylsyror |
TW224462B (zh) | 1992-02-24 | 1994-06-01 | Squibb & Sons Inc | |
US5378715A (en) | 1992-02-24 | 1995-01-03 | Bristol-Myers Squibb Co. | Sulfonamide endothelin antagonists |
TW215434B (zh) | 1992-03-07 | 1993-11-01 | Hoechst Ag | |
NZ247440A (en) | 1992-05-06 | 1995-04-27 | Squibb & Sons Inc | Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof |
US5514696A (en) | 1992-05-06 | 1996-05-07 | Bristol-Myers Squibb Co. | Phenyl sulfonamide endothelin antagonists |
AU4376893A (en) | 1992-05-19 | 1993-12-13 | Immunopharmaceutics, Inc. | Compounds that modulate endothelin activity |
TW287160B (zh) | 1992-12-10 | 1996-10-01 | Hoffmann La Roche | |
US5594201A (en) | 1993-05-10 | 1997-01-14 | Reinert, Sr.; Gary L. | Adjustable container set apparatus and method |
EP0617001B1 (en) | 1993-03-19 | 2000-01-26 | Merck & Co. Inc. | Phenoxyphenylacetic acid derivatives |
FI941826A (fi) | 1993-04-21 | 1994-10-22 | Takeda Chemical Industries Ltd | Menetelmät ja koostumukset elimen hypofunktion ennaltaehkäisemiseksi ja/tai terapeuttiseksi hoitamiseksi |
DE4321644A1 (de) | 1993-06-30 | 1995-01-12 | Nord Systemtechnik | Vorrichtung zur Feststellung von Undichtigkeiten an Bauteilen |
PT634175E (pt) | 1993-07-15 | 2001-06-29 | Hoffmann La Roche | Combinacao farmaceutica que contem um inibidor do sistema renina-angiotensina e o antagonista de endotelina |
US5965732A (en) | 1993-08-30 | 1999-10-12 | Bristol-Myers Squibb Co. | Sulfonamide endothelin antagonists |
GB9504854D0 (en) | 1994-03-31 | 1995-04-26 | Zeneca Ltd | Nitrogen derivatives |
GB9409618D0 (en) | 1994-05-13 | 1994-07-06 | Zeneca Ltd | Pyridine derivatives |
US5612359A (en) * | 1994-08-26 | 1997-03-18 | Bristol-Myers Squibb Company | Substituted biphenyl isoxazole sulfonamides |
CA2168154A1 (en) | 1995-02-06 | 1996-08-07 | Natesan Murugesan | Substituted biphenyl sulfonamide endothelin antagonists |
US5780473A (en) * | 1995-02-06 | 1998-07-14 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
DE19509950A1 (de) | 1995-03-18 | 1996-09-19 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
UA58494C2 (uk) | 1995-06-07 | 2003-08-15 | Зенека Лімітед | Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну |
GB9512697D0 (en) | 1995-06-22 | 1995-08-23 | Zeneca Ltd | Heterocyclic compounds |
US5846990A (en) * | 1995-07-24 | 1998-12-08 | Bristol-Myers Squibb Co. | Substituted biphenyl isoxazole sulfonamides |
JPH09124620A (ja) * | 1995-10-11 | 1997-05-13 | Bristol Myers Squibb Co | 置換ビフェニルスルホンアミドエンドセリン拮抗剤 |
US5580894A (en) | 1996-01-11 | 1996-12-03 | Howard University | Isoxazolyl enaminones |
JP2001523218A (ja) | 1996-02-20 | 2001-11-20 | ブリストル―マイヤーズ・スクイブ・カンパニー | ビフェニルイソキサゾール・スルホンアミドの製造法 |
US5856507A (en) * | 1997-01-21 | 1999-01-05 | Bristol-Myers Squibb Co. | Methods for the preparation of biphenyl isoxazole sulfonamides |
US5846985A (en) | 1997-03-05 | 1998-12-08 | Bristol-Myers Squibb Co. | Substituted biphenyl isoxazole sulfonamides |
MY153569A (en) | 1998-01-20 | 2015-02-27 | Mitsubishi Tanabe Pharma Corp | Inhibitors of ?4 mediated cell adhesion |
HUP0201320A2 (en) * | 1999-03-19 | 2002-08-28 | Bristol Myers Squibb Co | Methods for the preparation of biphenyl isoxazole sulfonamides and intermediates thereof |
-
2000
- 2000-03-02 HU HU0201320A patent/HUP0201320A2/hu unknown
- 2000-03-02 KR KR1020017011870A patent/KR20020004974A/ko not_active Application Discontinuation
- 2000-03-02 MX MXPA01009362A patent/MXPA01009362A/es unknown
- 2000-03-02 WO PCT/US2000/005521 patent/WO2000056685A1/en not_active Application Discontinuation
- 2000-03-02 EP EP00916019A patent/EP1165472A4/en not_active Withdrawn
- 2000-03-02 AU AU37189/00A patent/AU3718900A/en not_active Abandoned
- 2000-03-02 CA CA002367916A patent/CA2367916A1/en not_active Abandoned
- 2000-03-02 JP JP2000606550A patent/JP2002540088A/ja active Pending
- 2000-03-02 IL IL14470800A patent/IL144708A0/xx unknown
- 2000-03-20 US US09/528,819 patent/US6313308B1/en not_active Expired - Fee Related
-
2002
- 2002-02-22 HK HK02101358.2A patent/HK1039778A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
IL144708A0 (en) | 2002-06-30 |
JP2002540088A (ja) | 2002-11-26 |
US6313308B1 (en) | 2001-11-06 |
AU3718900A (en) | 2000-10-09 |
EP1165472A1 (en) | 2002-01-02 |
KR20020004974A (ko) | 2002-01-16 |
MXPA01009362A (es) | 2002-06-04 |
WO2000056685A1 (en) | 2000-09-28 |
HUP0201320A2 (en) | 2002-08-28 |
EP1165472A4 (en) | 2002-11-20 |
CA2367916A1 (en) | 2000-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1052183A1 (zh) | 製造tetrahydrobenzothiepines的方法 | |
ZA200204826B (en) | Preparation of concrete accellerator. | |
HU0103291D0 (en) | Process for the preparation of citalopram | |
IL187126A0 (en) | Process for the preparation of 4 - haloalkylnicotinonitriles | |
HUP0300856A3 (en) | Process for the preparation of substituted phenylacetonitriles | |
HUP0302594A3 (en) | Process for the preparation of phenethylamine derivatives | |
EP1300382A4 (en) | PROCESS FOR PREPARING LOWER OLEFINS | |
IL124542A0 (en) | Methods for the preparation of biphenyl isoxazole sulfonamides | |
IL155318A0 (en) | Methods for the preparation of biphenyl isoxazole sulfonamides | |
HK1039778A1 (zh) | 製造聯苯異噁唑基磺胺的方法 | |
AU8824201A (en) | Process for the preparation of dinapsoline | |
IL190807A0 (en) | Process for the preparation of 2-aminoethylpyridines | |
IL150897A0 (en) | Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides | |
IL138691A (en) | Process for the preparation of 3-acyl-indoles | |
HUP0202865A3 (en) | Process for the preparation of 2-cyanopyridines | |
HUP0400485A3 (en) | Process for the preparation of 5-phenylpentanoyl-ala-arginyl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-alanyl-arginyl-alanyl-4-aminophenylacetamide | |
IL137364A (en) | Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol | |
ZA971289B (en) | Methods for the preparation of biphenyl isoxazole sulfonamides | |
AU2166302A (en) | Process for the preparation of thiophenols | |
GB0012249D0 (en) | Process for the preparation of 11-oxaprostaglandins | |
IL155995A0 (en) | New process for the preparation of diaryl-4-amino-piperidinyl compounds | |
HU0003616D0 (en) | Process for the preparation of pyridyl-ketone | |
GB0028881D0 (en) | Process for the preparation of endo-5-norbornene-2-ol | |
GB0012996D0 (en) | Process for the preparation of endo-5-norbornene-2-ol | |
AU2002231651A1 (en) | Process for the preparation of morpholinones |